Literature DB >> 16140385

Acute neurotoxic effects of the fungal metabolite ochratoxin-A.

V Sava1, O Reunova, A Velasquez, R Harbison, J Sánchez-Ramos.   

Abstract

Ochratoxin-A (OTA) is a fungal metabolite with potential toxic effects on the central nervous system that have not yet been fully characterized. OTA has complex mechanisms of action that include evocation of oxidative stress, bioenergetic compromise, inhibition of protein synthesis, production of DNA single-strand breaks and formation of OTA-DNA adducts. The time course of acute effects of OTA were investigated in the context of DNA damage, DNA repair and global oxidative stress across six brain regions. Oxidative DNA damage, as measured with the "comet assay", was significantly increased in the six brain regions at all time points up to 72 h, with peak effects noted at 24 h in midbrain (MB), CP (caudate/putamen) and HP (hippocampus). Oxidative DNA repair activity (oxyguanosine glycosylase or OGG1) was inhibited in all regions at 6 h, but recovered to control levels in cerebellum (CB) by 72 h, and showed a trend to recovery in other regions of brain. Other indices of oxidative stress were also elevated. Lipid peroxidation and superoxide dismutase (SOD) increased over time throughout the brain. In light of the known vulnerability of the nigro-striatal dopaminergic neurons to oxidative stress, levels of striatal dopamine (DA) and its metabolites were also measured. Administration of OTA (0-6 mg/kg i.p.) to mice resulted in a dose-dependent decrease in striatal DA content and turnover with an ED50 of 3.2 mg/kg. A single dose of 3.5 mg/kg decreased the intensity of tyrosine hydroxylase immunoreactivity (TH(+)) in fibers of striatum, TH(+) cells in substantia nigra (SN) and TH(+) cells of the locus ceruleus. TUNEL staining did not reveal apoptotic profiles in MB, CP or in other brain regions and did not alter DARPP32 immunoreactivity in striatum. In conclusion, OTA caused acute depletion of striatal DA on a background of globally increased oxidative stress and transient inhibition of oxidative DNA repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140385     DOI: 10.1016/j.neuro.2005.07.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  22 in total

Review 1.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

2.  Ochratoxin A induces apoptosis in neuronal cells.

Authors:  Xiangnan Zhang; Christine Boesch-Saadatmandi; Yijia Lou; Siegfried Wolffram; Patricia Huebbe; Gerald Rimbach
Journal:  Genes Nutr       Date:  2009-01-16       Impact factor: 5.523

3.  Efflux at the Blood-Brain Barrier Reduces the Cerebral Exposure to Ochratoxin A, Ochratoxin α, Citrinin and Dihydrocitrinone.

Authors:  Matthias Behrens; Sabine Hüwel; Hans-Joachim Galla; Hans-Ulrich Humpf
Journal:  Toxins (Basel)       Date:  2021-04-30       Impact factor: 4.546

4.  Ochratoxin a inhibits mouse embryonic development by activating a mitochondrion-dependent apoptotic signaling pathway.

Authors:  Yan-Der Hsuuw; Wen-Hsiung Chan; Jau-Song Yu
Journal:  Int J Mol Sci       Date:  2013-01-07       Impact factor: 5.923

5.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

Review 6.  Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways.

Authors:  Kunio Doi; Koji Uetsuka
Journal:  Int J Mol Sci       Date:  2011-08-15       Impact factor: 5.923

7.  Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Authors:  Peter G Mantle; Christopher C Nolan
Journal:  Toxins (Basel)       Date:  2010-05-13       Impact factor: 4.546

Review 8.  A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.

Authors:  Janette H Hope; Bradley E Hope
Journal:  J Environ Public Health       Date:  2011-12-29

9.  Developmental toxicity of Ochratoxin A in rat embryo midbrain micromass cultures.

Authors:  Iwona Wilk-Zasadna; Maria Minta
Journal:  Int J Mol Sci       Date:  2008-12-27       Impact factor: 6.208

Review 10.  Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis.

Authors:  Alessandra Mezzelani; Martina Landini; Francesco Facchiano; Maria Elisabetta Raggi; Laura Villa; Massimo Molteni; Barbara De Santis; Carlo Brera; Anna Maria Caroli; Luciano Milanesi; Anna Marabotti
Journal:  Nutr Neurosci       Date:  2014-01-21       Impact factor: 4.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.